コンテンツへ移動
Endocannabinoid regulation of monoamines in psychiatric and neurological disorders 資料のプレビュー
閉じる資料のプレビュー
確認中…

Endocannabinoid regulation of monoamines in psychiatric and neurological disorders

著者: Elisabeth J Van Bockstaele
出版: New York : Springer, ©2013.
エディション/フォーマット:   電子書籍 : Document : Englishすべてのエディションとフォーマットを見る
データベース:WorldCat
概要:
The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in a variety of psychiatric (affective disorders) and neurological disorders (multiple sclerosis, pain). Despite increasing  続きを読む
評価:

(まだ評価がありません) 0 件のレビュー - 是非あなたから!

件名:
関連情報:

 

オンラインで入手

この資料へのリンク

オフラインで入手

&AllPage.SpinnerRetrieving; この資料の所蔵館を検索中…

詳細

ジャンル/形式: Electronic books
その他のフォーマット: Print version:
Endocannabinoid regulation of monoamines in psychiatric.
[S.l.] : Springer-Verlag New York, 2013
(OCoLC)841520677
資料の種類: Document, インターネット資料
ドキュメントの種類: インターネットリソース, コンピューターファイル
すべての著者/寄与者: Elisabeth J Van Bockstaele
ISBN: 9781461479406 1461479401 1461479398 9781461479390
OCLC No.: 852471079
注記: Includes index.
物理形態: 1 online resource.
コンテンツ: Endocannabinoids and monoamines: modulating the modulators --
Endocannabinoid-mediated synaptic plasticity --
Current cannabinoid receptor nomenclature and pharmacological principles --
Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction --
Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders --
Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers --
Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion --
Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function --
Endocannabinoids, Monoamines and Stress --
Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders --
Endocannabinoid Signaling and the Regulation of the Serotonin System --
Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors --
Involvement of serotonergic system in cannabinoid analgesia --
Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis.
責任者: Elisabeth J. van Bockstaele, editor.
その他の情報:

概要:

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders  続きを読む

レビュー

編集者のレビュー

出版社によるあらすじ

From the reviews: "This book reviews the expansion of our understanding of cannabinoid modulation of monoaminergic circuits and their interactions in a variety of psychiatric and neurological 続きを読む

 
ユーザーレビュー
GoodReadsのレビューを取得中…
DOGObooksのレビューを取得中…

タグ

まずはあなたから!
リクエストの確認

あなたは既にこの資料をリクエストしている可能性があります。このリクエストを続行してよろしければ、OK を選択してください。

リンクデータ


Primary Entity

<http://www.worldcat.org/oclc/852471079> # Endocannabinoid regulation of monoamines in psychiatric and neurological disorders
    a schema:MediaObject, schema:CreativeWork, schema:Book ;
   library:oclcnum "852471079" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/nyu> ;
   library:placeOfPublication <http://dbpedia.org/resource/New_York_City> ; # New York
   schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/medical_psychiatry_psychopharmacology> ; # MEDICAL--Psychiatry--Psychopharmacology
   schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/nervous_system_diseases_drug_therapy> ; # Nervous System Diseases--drug therapy
   schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/mental_disorders_drug_therapy> ; # Mental Disorders--drug therapy
   schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/cannabinoids_therapeutic_use> ; # Cannabinoids--Therapeutic use
   schema:about <http://id.loc.gov/authorities/subjects/sh2010103648> ; # Nervous system--Diseases--Treatment
   schema:about <http://id.worldcat.org/fast/845736> ; # Cannabinoids--Therapeutic use
   schema:about <http://id.worldcat.org/fast/1036124> ; # Nervous system--Diseases--Treatment
   schema:about <http://dewey.info/class/615.7827/e23/> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/endocannabinoids_therapeutic_use> ; # Endocannabinoids--therapeutic use
   schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/medical_pain_medicine> ; # MEDICAL--Pain Medicine
   schema:about <http://id.worldcat.org/fast/1016606> ; # Mental illness--Treatment
   schema:about <http://id.loc.gov/authorities/subjects/sh85083651> ; # Mental illness--Treatment
   schema:bookFormat schema:EBook ;
   schema:contributor <http://experiment.worldcat.org/entity/work/data/1411312578#Person/van_bockstaele_elisabeth_j> ; # Elisabeth J. Van Bockstaele
   schema:copyrightYear "2013" ;
   schema:datePublished "2013" ;
   schema:description "Endocannabinoids and monoamines: modulating the modulators -- Endocannabinoid-mediated synaptic plasticity -- Current cannabinoid receptor nomenclature and pharmacological principles -- Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction -- Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders -- Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers -- Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion -- Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function -- Endocannabinoids, Monoamines and Stress -- Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders -- Endocannabinoid Signaling and the Regulation of the Serotonin System -- Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors -- Involvement of serotonergic system in cannabinoid analgesia -- Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis."@en ;
   schema:description "The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in a variety of psychiatric (affective disorders) and neurological disorders (multiple sclerosis, pain). Despite increasing evidence from preclinical data suggesting that therapeutic use of cannabinoid-based drugs may outweigh any potential risks in certain serious medical conditions, the debate surrounding its widespread utility continues as regulatory concerns preclude a smooth transition of promising preclinical studies into clinical trial testing. This may persist in the near future as state and federal governments debate over regulation of medicinal applications of cannabis. Applications for medicinal cannabinoids that are already under investigation include the treatment of nausea, anorexia, neurodegeneration, inflammation, excitotoxicity and pain. The appetitive and anti-emetic properties of cannabinoids have led to the approval of their use in chemotherapy and AIDS patients. There is growing evidence for therapeutic cannabinoid effects on inflammatory and excitotoxic cellular processes that are linked to epilepsy, Parkinson's disease, amyotrophic lateral sclerosis, spasticity, and central nervous system injury. The chapters, herein, review and discuss current insights into the brain endocannabinoid system, cannabinoid receptor signaling on synaptic plasticity, potential therapeutic applications with a particular focus on endocannabinoid modulation of dopaminergic, noradrenergic and serotonergic circuitry. The potential for establishing cannabinoid-monoaminergic interactions as a novel target in the development of improved treatment strategies for psychiatric and neurological disorders is promising and will require future clinical studies to determine whether promising pre-clinical findings translate into new therapies."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/1411312578> ;
   schema:genre "Electronic books"@en ;
   schema:inLanguage "en" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/841520677> ;
   schema:name "Endocannabinoid regulation of monoamines in psychiatric and neurological disorders"@en ;
   schema:productID "852471079" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/852471079#PublicationEvent/new_york_springer_2013> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/1411312578#Agent/springer> ; # Springer
   schema:url <http://dx.doi.org/10.1007/978-1-4614-7940-6> ;
   schema:url <http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=606343> ;
   schema:url <http://www.myilibrary.com?id=517034> ;
   schema:url <http://site.ebrary.com/id/10733550> ;
   schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=1317800> ;
   schema:workExample <http://worldcat.org/isbn/9781461479390> ;
   schema:workExample <http://worldcat.org/isbn/9781461479406> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/852471079> ;
    .


Related Entities

<http://dbpedia.org/resource/New_York_City> # New York
    a schema:Place ;
   schema:name "New York" ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Person/van_bockstaele_elisabeth_j> # Elisabeth J. Van Bockstaele
    a schema:Person ;
   schema:familyName "Van Bockstaele" ;
   schema:givenName "Elisabeth J." ;
   schema:name "Elisabeth J. Van Bockstaele" ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/endocannabinoids_therapeutic_use> # Endocannabinoids--therapeutic use
    a schema:Intangible ;
   schema:name "Endocannabinoids--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/medical_pain_medicine> # MEDICAL--Pain Medicine
    a schema:Intangible ;
   schema:name "MEDICAL--Pain Medicine"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/medical_psychiatry_psychopharmacology> # MEDICAL--Psychiatry--Psychopharmacology
    a schema:Intangible ;
   schema:name "MEDICAL--Psychiatry--Psychopharmacology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/mental_disorders_drug_therapy> # Mental Disorders--drug therapy
    a schema:Intangible ;
   schema:name "Mental Disorders--drug therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/nervous_system_diseases_drug_therapy> # Nervous System Diseases--drug therapy
    a schema:Intangible ;
   schema:name "Nervous System Diseases--drug therapy"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2010103648> # Nervous system--Diseases--Treatment
    a schema:Intangible ;
   schema:name "Nervous system--Diseases--Treatment"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh85083651> # Mental illness--Treatment
    a schema:Intangible ;
   schema:name "Mental illness--Treatment"@en ;
    .

<http://id.worldcat.org/fast/1016606> # Mental illness--Treatment
    a schema:Intangible ;
   schema:name "Mental illness--Treatment"@en ;
    .

<http://id.worldcat.org/fast/1036124> # Nervous system--Diseases--Treatment
    a schema:Intangible ;
   schema:name "Nervous system--Diseases--Treatment"@en ;
    .

<http://id.worldcat.org/fast/845736> # Cannabinoids--Therapeutic use
    a schema:Intangible ;
   schema:name "Cannabinoids--Therapeutic use"@en ;
    .

<http://worldcat.org/isbn/9781461479390>
    a schema:ProductModel ;
   schema:isbn "1461479398" ;
   schema:isbn "9781461479390" ;
    .

<http://worldcat.org/isbn/9781461479406>
    a schema:ProductModel ;
   schema:isbn "1461479401" ;
   schema:isbn "9781461479406" ;
    .

<http://www.worldcat.org/oclc/841520677>
    a schema:CreativeWork ;
   rdfs:label "Endocannabinoid regulation of monoamines in psychiatric." ;
   schema:description "Print version:" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/852471079> ; # Endocannabinoid regulation of monoamines in psychiatric and neurological disorders
    .

<http://www.worldcat.org/title/-/oclc/852471079>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
   schema:about <http://www.worldcat.org/oclc/852471079> ; # Endocannabinoid regulation of monoamines in psychiatric and neurological disorders
   schema:dateModified "2016-05-11" ;
   void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

ウインドウを閉じる

WorldCatにログインしてください 

アカウントをお持ちではないですか?簡単に 無料アカウントを作成することができます。.